Binh Dinh Pharmaceutical and Medical Equipment JSC (DBD) - Cash Flow Conversion Efficiency

Latest as of March 2026: -0.075x

Based on the latest financial reports, Binh Dinh Pharmaceutical and Medical Equipment JSC (DBD) has a cash flow conversion efficiency ratio of -0.075x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₫-135.66 Billion ≈ $-5.15 Million USD) by net assets (₫1.82 Trillion ≈ $69.03 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See net asset quality index of Binh Dinh Pharmaceutical and Medical Equ to measure how much of total assets are equity-financed.

Binh Dinh Pharmaceutical and Medical Equipment JSC - Cash Flow Conversion Efficiency Trend (2020–2025)

This chart illustrates how Binh Dinh Pharmaceutical and Medical Equipment JSC's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check DBD cash flow quality score to evaluate the quality of earnings relative to operating cash generation.

Binh Dinh Pharmaceutical and Medical Equipment JSC Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Binh Dinh Pharmaceutical and Medical Equipment JSC ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
PULSION Medical Systems SE MU:PUS	0.160x
Suheung Capsul KO:008490	0.017x
Sierra Metals Inc. TO:SMT	0.249x
RAINBOW RARE EARTHS LTD F:RR1	N/A
Honma Golf Limited F:HF5	0.008x
Saturn Metals Ltd AU:STN	-0.007x
Merafe JSE:MRF	-0.033x
GTS Internasional Tbk PT JK:GTSI	0.175x

Annual Cash Flow Conversion Efficiency for Binh Dinh Pharmaceutical and Medical Equipment JSC (2020–2025)

The table below shows the annual cash flow conversion efficiency of Binh Dinh Pharmaceutical and Medical Equipment JSC from 2020 to 2025. For the full company profile with market capitalisation and key ratios, see market value of Binh Dinh Pharmaceutical and Medical Equ.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	₫1.72 Trillion ≈ $65.40 Million	₫615.19 Billion ≈ $23.37 Million	0.357x	+124.27%
2024-12-31	₫1.66 Trillion ≈ $63.11 Million	₫264.73 Billion ≈ $10.06 Million	0.159x	-22.33%
2023-12-31	₫1.43 Trillion ≈ $54.44 Million	₫293.99 Billion ≈ $11.17 Million	0.205x	+68.50%
2022-12-31	₫1.36 Trillion ≈ $51.49 Million	₫165.01 Billion ≈ $6.27 Million	0.122x	+18.13%
2021-12-31	₫1.14 Trillion ≈ $43.33 Million	₫117.57 Billion ≈ $4.47 Million	0.103x	-52.14%
2020-12-31	₫988.63 Billion ≈ $37.56 Million	₫212.91 Billion ≈ $8.09 Million	0.215x	--

About Binh Dinh Pharmaceutical and Medical Equipment JSC

VN:DBD Vietnam Drug Manufacturers - Specialty & Generic

Market Cap

$178.06 Million

₫4.69 Trillion VND

Market Cap Rank

#17012 Global

#98 in Vietnam

Share Price

₫49600.00

Change (1 day)

+0.61%

52-Week Range

₫48050.00 - ₫55500.00

All Time High

₫62000.00